Oncolytics Biotech, Inc. (ONCY) trading halted with news pending
- Deutsche helps lift European stocks before Yellen, Draghi
- BlackBerry (BBRY) Tops Q2 EPS by 5c; Will End Internal Hardware Development; Boosts FY17 Outlook
- Nike (NKE) Tops Q1 EPS by 17c; Futures Orders Miss Views
- Oil climbs after industry data shows U.S. inventory draw
- Tempur Sealy (TPX) Updates on Outlook; Sees Q3 Sales Below Prior Expectations
Oncolytics Biotech, Inc. (NASDAQ: ONCY) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Galectin Therapeutics (GALT) sinks 39% as trading resumes
- Kite Pharma (KITE) Announces Positive Topline Data from KTE-C19 ZUMA-1 Study in Aggressive NHL
- Pain Therapeutics (PTIE) Announces Receipt of FDA Complete Response Letter for REMOXY ER (DRRX)
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!